It remains under clinical investigation and has not yet received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
The MHRA states that patients currently treated privately with the 2.4mg once-weekly semaglutide injection can be transitioned straight to semaglutide 25mg tablets once daily
Some are already registered in South Africa, while others are still on the way
Patients are often surprised to learn that this dose isnt universally necessarysome continue to see success at 1.7 mg, while others feel better staying at 1 mg due to tolerability
Alharris E, Alghetaa H, Seth R, Chatterjee S, Singh NP, Nagarkatti M, et al
Use near term weakness related to a Fed that is moving too slow for the markets liking to reposition portfolio to sectors and stocks that have lagged behind for most of the past several years but will benefit the most from the more aggressive Fed action we expect to come